DHS, DOHH, and eiF5a inhibitors have been investigated for different cancer types in vitro and in vivo. GC7 is the hypusine-axis inhibitor that has been the most studied for cancer treatment and other pathologies.17 This evidence concerns the gene EIF5A and cancer.